


Healthcare News Roundup: Neuro
HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
HSMN NewsFeed - 26 Mar 2007
Smith & Nephew Issues Nationwide Recall of RF Denervation Probes Used for the Spine
Smith & Nephew Issues Nationwide Recall of RF Denervation Probes Used for the Spine
HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
HSMN NewsFeed - 20 Mar 2007
Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed - 16 Mar 2007
Uroplasty Announces Agreement to Purchase Urgent(R) PC Intellectual Property Assets
Uroplasty Announces Agreement to Purchase Urgent(R) PC Intellectual Property Assets
HSMN NewsFeed - 15 Mar 2007
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
Alexian Brothers Hospital Network To Bring Advanced Brain Mapping Technology To Chicagoland
HSMN NewsFeed - 13 Mar 2007
Mazor SpineAssist Delivers 98 Percent Reduction in Surgeon Radiation Exposure
Mazor SpineAssist Delivers 98 Percent Reduction in Surgeon Radiation Exposure
HSMN NewsFeed - 13 Mar 2007
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
HSMN NewsFeed - 6 Mar 2007
Applied NeuroSolutions Hires Top Ranked Analyst, Ryan Rauch, to Direct its Investor Relations Program
Applied NeuroSolutions Hires Top Ranked Analyst, Ryan Rauch, to Direct its Investor Relations Program
HSMN NewsFeed - 5 Mar 2007
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HSMN NewsFeed - 5 Mar 2007
NeuroLogica Receives Canadian Medical Device License for the CereTom(TM) CT Scanner
NeuroLogica Receives Canadian Medical Device License for the CereTom(TM) CT Scanner
HSMN NewsFeed - 5 Mar 2007
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
HSMN NewsFeed - 28 Feb 2007
St. Jude Medical Announces Spinal Cord Stimulation Pilot Study for Chronic Angina
St. Jude Medical Announces Spinal Cord Stimulation Pilot Study for Chronic Angina
HSMN NewsFeed - 27 Feb 2007
Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
HSMN NewsFeed - 26 Feb 2007
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to University Clinic in Jena, Germany
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to University Clinic in Jena, Germany
HSMN NewsFeed - 23 Feb 2007
Swedish Medical Center Enhances Neuroscience Institute With Portable CT Scanner from NeuroLogica
Swedish Medical Center Enhances Neuroscience Institute With Portable CT Scanner from NeuroLogica
HSMN NewsFeed - 20 Feb 2007
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
HSMN NewsFeed - 15 Feb 2007
St. Jude Medical Announces FDA Clearance of Spinal Cord Stimulation Leads for Patients with Low Back Pain
St. Jude Medical Announces FDA Clearance of Spinal Cord Stimulation Leads for Patients with Low Back Pain
HSMN NewsFeed - 15 Feb 2007
Top Hospitals Use Arctic Sun(R) Device to Chill Patients, Avert Brain Damage
Top Hospitals Use Arctic Sun(R) Device to Chill Patients, Avert Brain Damage
HSMN NewsFeed - 14 Feb 2007
Misonix Expands International Distribution of Neuroaspirator Product Line into Eastern and Central Europe
Misonix Expands International Distribution of Neuroaspirator Product Line into Eastern and Central Europe
HSMN NewsFeed - 14 Feb 2007
Scient'x USA Announces 510(K) Clearance for Isobar LP(R) Low Profile Pedicle Screw System
Scient'x USA Announces 510(K) Clearance for Isobar LP(R) Low Profile Pedicle Screw System
HSMN NewsFeed - 13 Feb 2007
N Spine Receives 510(k) Clearance of Its NFix II Dynamic Stabilization System for the Lumbar Spine
N Spine Receives 510(k) Clearance of Its NFix II Dynamic Stabilization System for the Lumbar Spine
HSMN NewsFeed - 12 Feb 2007
Aesculap Implant Systems, Inc. Initiates Study of the Activ-L(TM) Artificial Disc
Aesculap Implant Systems, Inc. Initiates Study of the Activ-L(TM) Artificial Disc
HSMN NewsFeed - 12 Feb 2007
Integra LifeSciences Announces the Launch of Integra Mozaik Osteoconductive Scaffold
Integra LifeSciences Announces the Launch of Integra Mozaik Osteoconductive Scaffold
HSMN NewsFeed - 8 Feb 2007
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
GlaxoSmithKline and XenoPort Announce Agreement on Late-Stage Compound for RLS and Neuropathic Pain
